Given a mean corpuscular volume of 78.4 fL, total iron‑binding capacity of 33 µg/dL, and ferritin of 196 ng/mL, does this indicate iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This is NOT iron deficiency

Based on your ferritin of 196 ng/mL, you do not have iron deficiency anemia, despite the low MCV and abnormally low TIBC.

Why This is Not Iron Deficiency

Your ferritin level of 196 ng/mL is well above all diagnostic thresholds for iron deficiency:

  • Ferritin >150 ng/mL essentially excludes absolute iron deficiency, even in the presence of inflammation 1
  • The British Society of Gastroenterology guidelines explicitly state that ferritin above 150 ng/mL is "unlikely to occur with absolute iron deficiency, even in the presence of inflammation" 1
  • The AGA guidelines recommend a ferritin threshold of <45 ng/mL for diagnosing iron deficiency (sensitivity 85%, specificity 92%) 2
  • Even the more conservative cutoff of <15 ng/mL has 99% specificity 2

Your ferritin is more than 4 times higher than the 45 ng/mL threshold and more than 13 times higher than the 15 ng/mL threshold.

Understanding Your Abnormal Results

The Low MCV (78.4 fL)

While microcytosis (low MCV) commonly suggests iron deficiency, MCV has limited specificity 1. Your microcytosis with normal-to-high ferritin suggests alternative diagnoses:

  • Thalassemia trait (most likely given MCV disproportionately low relative to degree of anemia)
  • Anemia of chronic disease
  • Sideroblastic anemia
  • Hemoglobinopathies

You should have hemoglobin electrophoresis performed to evaluate for thalassemia, particularly if you have appropriate ethnic background (Mediterranean, Asian, African, Middle Eastern descent) 1.

The Abnormally Low TIBC (33 µg/dL)

Your TIBC is dramatically low (normal range typically 250-450 µg/dL). This is the opposite of what occurs in iron deficiency:

  • Iron deficiency causes elevated TIBC (typically >350 µg/dL) 1, 3
  • Low TIBC suggests chronic inflammation, liver disease, malnutrition, or nephrotic syndrome 4
  • Research shows TIBC <250 µg/dL makes iron deficiency highly unlikely (only 3% had iron deficiency) 3

Clinical Pitfall to Avoid

Do not treat with iron supplementation based solely on low MCV. Ferritin is the most specific test for iron deficiency in the absence of inflammation 1. Your elevated ferritin definitively rules out iron deficiency. Unnecessary iron supplementation could cause iron overload and mask the true underlying diagnosis.

Recommended Next Steps

  1. Hemoglobin electrophoresis to evaluate for thalassemia trait or other hemoglobinopathies 1
  2. Inflammatory markers (CRP, ESR) to assess for chronic disease
  3. Comprehensive metabolic panel to evaluate liver and kidney function (given the extremely low TIBC)
  4. Complete blood count with peripheral smear review for morphologic abnormalities

The combination of microcytosis, normal-to-elevated ferritin, and markedly low TIBC points toward a diagnosis other than iron deficiency—most likely thalassemia trait or anemia of chronic disease.

Related Questions

What is the most likely diagnosis for a patient with anemia, low mean corpuscular volume (MCV), and high ferritin?
What is the appropriate management for a patient with ferritin 10.6 ng/mL, total iron‑binding capacity 460 µg/dL, transferrin saturation 13 %, erythrocyte sedimentation rate 22 mm/hr, and mean corpuscular volume 82 fL?
What does a ferritin level of 41 µg/L indicate and how should iron deficiency be evaluated and managed?
In a 49-year-old woman with low transferrin (181 mg/dL), low total iron‑binding capacity (226 µg/dL), and elevated ferritin (264 ng/mL), what is the most likely diagnosis and what are the appropriate next steps in management?
How should I interpret iron studies showing serum iron 79 µg/dL, total iron‑binding capacity (TIBC) 272 µg/dL, transferrin saturation 29 %, and ferritin 243 ng/mL?
What is the appropriate assessment and plan for a 79‑year‑old woman with a history of coronary artery disease status post triple coronary artery bypass graft (left internal mammary artery to left anterior descending artery and saphenous vein grafts to obtuse marginal branches), hypertension, hyperlipidemia, chronic obstructive pulmonary disease, obstructive sleep apnea, and heart failure with reduced ejection fraction (35‑40 %), who presented with severe hypertension and chest pain, was diagnosed with a non‑ST‑elevation myocardial infarction, underwent percutaneous coronary intervention with a drug‑eluting stent to the obtuse marginal branch, and now has bradycardia, hypotension, mildly elevated creatinine, and is taking aspirin, ticagrelor, bempedoic‑acid/ezetimibe, losartan/hydrochlorothiazide, isosorbide mononitrate, and sertraline?
Are smoking and alcohol relevant to lichen sclerosus?
What is the most common cause of mortality in patients with familial Mediterranean fever?
What is the prognosis for bilateral cerebellar hemisphere lesions and a right posterior parietal lobe lesion?
In a patient with microcytic anemia and elevated ferritin, what is the appropriate work‑up and management for a mildly elevated bilirubin?
A 17-year-old female presents with a persistent right-sided headache for two weeks, a past history of episodic left-sided headaches for a year, left palatal weakness, a right extensor plantar response, a normal complete blood count, and an elevated erythrocyte sedimentation rate of 85 mm/hr; how should she be investigated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.